These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2853169)

  • 1. High-performance liquid chromatographic determination of a new beta-lactamase inhibitor and its metabolite in combination therapy with piperacillin in biological materials.
    Marunaka T; Maniwa M; Matsushima E; Minami Y
    J Chromatogr; 1988 Sep; 431(1):87-101. PubMed ID: 2853169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of tazobactam and piperacillin in human plasma, serum, bile and urine by gradient elution reversed-phase high-performance liquid chromatography.
    Ocampo AP; Hoyt KD; Wadgaonkar N; Carver AH; Puglisi CV
    J Chromatogr; 1989 Nov; 496(1):167-79. PubMed ID: 2556418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Degradation of beta-lactamase inhibitor, (2S,3R,5S)-3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-yl-methyl)-4-thi a-1- azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide (YTR-830H), in aqueous solutions and alkaline methanol solution: pathway and structural elucidation of products.
    Marunaka T; Matsushima E; Minami Y; Yoshida K; Azuma R
    Chem Pharm Bull (Tokyo); 1988 Nov; 36(11):4478-87. PubMed ID: 2854499
    [No Abstract]   [Full Text] [Related]  

  • 4. High-performance liquid chromatographic determination of tazobactam and piperacillin in human plasma and urine.
    Augey V; Grosse PY; Albert G; Audran M; Bressolle F
    J Chromatogr B Biomed Appl; 1996 Jun; 682(1):125-36. PubMed ID: 8832433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of cefodizime in biological materials by high-performance liquid chromatography.
    Marunaka T; Matsushima E; Maniwa M
    J Chromatogr; 1987 Sep; 420(2):329-39. PubMed ID: 3693504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New and rapid fully automated method for determination of tazobactam and piperacillin in fatty tissue and serum by column-switching liquid chromatography.
    Trittler R; Ehrlich M; Galla TJ; Horch RE; Kümmerer K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Aug; 775(2):127-32. PubMed ID: 12113978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and optimization of a reversed-phase high-performance liquid chromatographic method for the determination of piperacillin and tazobactam in tazocin injectable powder.
    Marselos SC; Archontaki HA
    J Pharm Biomed Anal; 2002 Jul; 29(5):787-93. PubMed ID: 12093510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A UHPLC-MS/MS method for the simultaneous determination of piperacillin and tazobactam in plasma (total and unbound), urine and renal replacement therapy effluent.
    Naicker S; Guerra Valero YC; Ordenez Meija JL; Lipman J; Roberts JA; Wallis SC; Parker SL
    J Pharm Biomed Anal; 2018 Jan; 148():324-333. PubMed ID: 29080413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-performance liquid chromatographic determination of tazobactam by precolumn derivatization.
    Peyrin E; Guillaume Y; Guinchard C
    J Chromatogr B Biomed Appl; 1995 Oct; 672(1):160-4. PubMed ID: 8590930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A simple and rapid RP-HPLC method for the simultaneous determination of piperacillin and tazobactam in human plasma.
    Veillette JJ; Winans SA; Forland SC; Maskiewicz VK
    J Pharm Biomed Anal; 2016 Nov; 131():80-86. PubMed ID: 27529601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation and stability of piperacillin and tazobactam in plasma and ultrafiltrate from patients undergoing continuous venovenous hemofiltration by HPLC.
    Arzuaga A; Isla A; Gascón AR; Maynar J; Martín A; Solinís MA; Toral D; Pedraz JL
    Biomed Chromatogr; 2005 Oct; 19(8):570-8. PubMed ID: 15828066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of piperacillin and mezlocillin in human serum and urine by high-performance liquid chromatography after derivatisation with 1,2,4-triazole.
    García-Gonzalez JC; Méndez R; Martín-Villacorta J
    J Chromatogr A; 1998 Jul; 812(1-2):213-20. PubMed ID: 9691320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial activities of piperacillin alone and in combination with tazobactam against beta-lactamase-producing bacteria.
    Chang SC; Hsu LY; Luh KT; Hsieh WC
    J Formos Med Assoc; 1991 Oct; 90(10):947-52. PubMed ID: 1685175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the renal excretion of tazobactam by piperacillin.
    Komuro M; Maeda T; Kakuo H; Matsushita H; Shimada J
    J Antimicrob Chemother; 1994 Oct; 34(4):555-64. PubMed ID: 7868407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of piperacillin and tazobactam in plasma and subcutaneous interstitial fluid in critically ill patients receiving continuous venovenous haemodiafiltration.
    Varghese JM; Jarrett P; Boots RJ; Kirkpatrick CM; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2014 Apr; 43(4):343-8. PubMed ID: 24612982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High performance liquid chromatographic determination of plasma free and total tazobactam and piperacillin.
    Di Giovamberardino G; Ferrannini M; Testore GP; Federici G; Pastore A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jan; 877(1-2):86-8. PubMed ID: 19058767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic drug monitoring of piperacillin and tazobactam by RP-HPLC of residual blood specimens.
    Verhoven SM; Groszek JJ; Fissell WH; Seegmiller A; Colby J; Patel P; Verstraete A; Shotwell M
    Clin Chim Acta; 2018 Jul; 482():60-64. PubMed ID: 29596815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Basic and clinical studies on tazobactam/piperacillin in pediatric field].
    Motohiro T; Nagai K; Yamada T; Oki S; Yamada T; Yoshinaga Y; Tsumura N; Oda K; Sakata Y; Kato H; Imai S; Morita J; Matsuo Y; Ikezawa S; Takahgashi K; Fukuda T; Yamashita Y; Aramaki M; Hayashi M; Yamakawa R; Ono-E ; Tananari Y; Tsutsumi T; Hoshuyama A; Aida K
    Jpn J Antibiot; 1998 Jun; 51(6):413-31. PubMed ID: 9755831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A rapid, LC-MS/MS assay for quantification of piperacillin and tazobactam in human plasma and pleural fluid; application to a clinical pharmacokinetic study.
    Popowicz ND; O'Halloran SJ; Fitzgerald D; Lee YCG; Joyce DA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Apr; 1081-1082():58-66. PubMed ID: 29505960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behaviour of beta-lactamase-positive and -negative Staphylococcus aureus isolates in susceptibility tests with piperacillin/tazobactam and other beta-lactam/beta-lactamase inhibitor combinations.
    Bonfiglio G; Livermore DM
    J Antimicrob Chemother; 1993 Sep; 32(3):431-44. PubMed ID: 8262865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.